Oxaliplatin Injection, Solution, Concentrate
Product Images NDC 31722-358

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 31722-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo (Camberlogo)

FDA Label Image

Oxaliplatinfigure1 (Oxaliplatinfigure1)

A Kaplan-Meier survival curve illustrating disease-free survival (DFS) probability over time in months for two treatment arms labeled FOLFOX4 and LV5FU2. The solid line represents FOLFOX4, and the dashed line represents LV5FU2. The chart includes the number of patients at risk over time and statistical data including hazard ratio and p-value from a stratified logrank test.*

FDA Label Image

Oxaliplatinfigure2 (Oxaliplatinfigure2)

A Kaplan-Meier survival curve graph depicting disease-free survival (DFS) probability over time in months for two treatment arms: FOLFOX4 and LV5FU2 in Stage III patients. The graph includes a hazard ratio with 95% confidence interval and a p-value from a logrank test, illustrating comparative survival outcomes between treatments.*

FDA Label Image

Oxaliplatinfigure3 (Oxaliplatinfigure3)

A survival curve graph showing median survival over 24 months for three treatment groups: Oxaliplatin plus 5-FU/LV (solid line), Oxaliplatin plus Irinotecan (dashed line), and Irinotecan plus 5-FU/LV (dotted line). The y-axis represents the percentage of patients surviving, and the x-axis shows time in months. Median survival times are 19.4, 17.6, and 14.6 months respectively, with a p-value of less than 0.0001 indicating statistical significance.*

FDA Label Image

Oxaliplatinfigure4 (Oxaliplatinfigure4)

Label for Oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL) concentrate for injection by intravenous route. The single-dose vial label from Camber Pharmaceuticals, Inc. includes storage instructions, a cytotoxic warning, and manufacturer details. The label states not to mix with sodium chloride or chloride-containing solutions.*

FDA Label Image

Oxaliplatinfigure5 (Oxaliplatinfigure5)

The packaging label for Oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL) by Camber Pharmaceuticals, Inc. It is a single-dose vial for intravenous infusion after dilution, with warnings about cytotoxicity and instructions to avoid mixing with sodium chloride-containing solutions. The label includes storage instructions, manufacturer and contact information, and a barcode.*

FDA Label Image

Oxaliplatinfigure6 (Oxaliplatinfigure6)

Oxaliplatin Injection, USP 100 mg/20 mL (5 mg/mL) solution concentrate for intravenous infusion in a 20 mL single-dose vial. The label includes storage instructions, warnings against mixing with sodium chloride solutions, and manufacturer information for Camber Pharmaceuticals, Inc. Barcode and contact number are also displayed.*

FDA Label Image

Oxaliplatinfigure7 (Oxaliplatinfigure7)

Packaging label for Oxaliplatin Injection, USP 100 mg/20 mL (5 mg/mL) concentrate for intravenous infusion. The label states it is a cytotoxic agent, preservative-free sterile aqueous solution, and single-dose vial. Manufactured by HETERO Labs Limited for Camber Pharmaceuticals, Inc. Includes storage instructions and warnings against mixing with sodium chloride solutions.*

FDA Label Image

Oxaliplatinstructure (Oxaliplatinstructure)

Chemical structure of Oxaliplatin, showing the central platinum atom coordinated with a cyclohexane ring carrying two amine groups and an oxalate ligand with two carboxyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.